Mechanism for FGF-1 to regulate biogenesis of apoE-HDL in astrocytes. 2007

Jin-Ichi Ito, and Yuko Nagayasu, and Kuniko Okumura-Noji, and Rui Lu, and Tomo Nishida, and Yutaka Miura, and Kiyofumi Asai, and Alireza Kheirollah, and Seiichi Nakaya, and Shinji Yokoyama
Biochemistry, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.

Fibroblast growth factor-1 (FGF-1) is secreted by astrocytes and stimulates apolipoprotein E (apoE)-HDL biogenesis by an autocrine mechanism to help in recovery from brain injury. In apoE-deficient mouse astrocytes, FGF-1 stimulated cholesterol biosynthesis without enhancing its release, indicating a signaling pathway independent of apoE biosynthesis upregulation. SU5402, an inhibitor of FGF receptor, inhibited FGF-1-induced phosphorylation of MEK, ERK, and Akt, as well as all the apoE-HDL biogenesis-related events in rat astrocytes. LY294002, an inhibitor of phosphatidylinositide 3-OH kinase (PI3K) and of Akt phosphorylation, inhibited apoE-HDL secretion but not cholesterol biosynthesis, whereas U0126, an inhibitor of MEK and of ERK phosphorylation, inhibited cholesterol biosynthesis but not apoE-HDL secretion. Increase of apoE-mRNA by FGF-1 was not influenced by either inhibitor. When rat apoE/pcDNA3.his was transfected to transformed rat astrocyte GA-1 cells that otherwise do not synthesize apoE (GA-1/25), FGF-1 did not influence apoE-mRNA, but did increase the apoE secretion and Akt phosphorylation that were suppressed by LY294002. Lipid biosynthesis was increased by FGF-1 in GA-1/25 cells and suppressed by U0126. FGF-1 upregulates apoE-HDL biogenesis by three independent signaling pathways. The PI3K/Akt pathway upregulates secretion of apoE/apoE-HDL, the MEK/ERK pathway stimulates cholesterol biosynthesis, and an unknown pathway enhances apoE transcription.

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009025 Morpholines Tetrahydro-1,4-Oxazines,Tetrahydro 1,4 Oxazines
D009570 Nitriles Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE. Nitrile
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D002070 Butadienes Four carbon unsaturated hydrocarbons containing two double bonds. Butadiene Derivative,Butadiene Derivatives,Derivative, Butadiene,Derivatives, Butadiene
D002867 Chromones 1,4-Benzopyrones,Chromone,1,4 Benzopyrones
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001057 Apolipoproteins E A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III. Apo-E,Apo E,Apo E Isoproteins,ApoE,Apolipoprotein E Isoproteins,Apoprotein (E),Apoproteins E,Isoproteins, Apo E,Isoproteins, Apolipoprotein E

Related Publications

Jin-Ichi Ito, and Yuko Nagayasu, and Kuniko Okumura-Noji, and Rui Lu, and Tomo Nishida, and Yutaka Miura, and Kiyofumi Asai, and Alireza Kheirollah, and Seiichi Nakaya, and Shinji Yokoyama
August 2000, Journal of molecular neuroscience : MN,
Jin-Ichi Ito, and Yuko Nagayasu, and Kuniko Okumura-Noji, and Rui Lu, and Tomo Nishida, and Yutaka Miura, and Kiyofumi Asai, and Alireza Kheirollah, and Seiichi Nakaya, and Shinji Yokoyama
June 2011, Annals of medicine,
Jin-Ichi Ito, and Yuko Nagayasu, and Kuniko Okumura-Noji, and Rui Lu, and Tomo Nishida, and Yutaka Miura, and Kiyofumi Asai, and Alireza Kheirollah, and Seiichi Nakaya, and Shinji Yokoyama
June 2009, Journal of lipid research,
Jin-Ichi Ito, and Yuko Nagayasu, and Kuniko Okumura-Noji, and Rui Lu, and Tomo Nishida, and Yutaka Miura, and Kiyofumi Asai, and Alireza Kheirollah, and Seiichi Nakaya, and Shinji Yokoyama
August 2022, International journal of molecular sciences,
Jin-Ichi Ito, and Yuko Nagayasu, and Kuniko Okumura-Noji, and Rui Lu, and Tomo Nishida, and Yutaka Miura, and Kiyofumi Asai, and Alireza Kheirollah, and Seiichi Nakaya, and Shinji Yokoyama
May 1996, Brain research. Molecular brain research,
Jin-Ichi Ito, and Yuko Nagayasu, and Kuniko Okumura-Noji, and Rui Lu, and Tomo Nishida, and Yutaka Miura, and Kiyofumi Asai, and Alireza Kheirollah, and Seiichi Nakaya, and Shinji Yokoyama
July 2019, Scientific reports,
Jin-Ichi Ito, and Yuko Nagayasu, and Kuniko Okumura-Noji, and Rui Lu, and Tomo Nishida, and Yutaka Miura, and Kiyofumi Asai, and Alireza Kheirollah, and Seiichi Nakaya, and Shinji Yokoyama
November 2011, Atherosclerosis,
Jin-Ichi Ito, and Yuko Nagayasu, and Kuniko Okumura-Noji, and Rui Lu, and Tomo Nishida, and Yutaka Miura, and Kiyofumi Asai, and Alireza Kheirollah, and Seiichi Nakaya, and Shinji Yokoyama
February 2006, Journal of atherosclerosis and thrombosis,
Jin-Ichi Ito, and Yuko Nagayasu, and Kuniko Okumura-Noji, and Rui Lu, and Tomo Nishida, and Yutaka Miura, and Kiyofumi Asai, and Alireza Kheirollah, and Seiichi Nakaya, and Shinji Yokoyama
January 2010, Advances in experimental medicine and biology,
Jin-Ichi Ito, and Yuko Nagayasu, and Kuniko Okumura-Noji, and Rui Lu, and Tomo Nishida, and Yutaka Miura, and Kiyofumi Asai, and Alireza Kheirollah, and Seiichi Nakaya, and Shinji Yokoyama
December 2001, International journal of cancer,
Copied contents to your clipboard!